Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 25% ± 6% | |
fibroblast | 7 studies | 26% ± 8% | |
epithelial cell | 5 studies | 20% ± 2% | |
endothelial cell of lymphatic vessel | 5 studies | 31% ± 12% | |
smooth muscle cell | 5 studies | 24% ± 6% | |
connective tissue cell | 5 studies | 19% ± 4% | |
non-classical monocyte | 4 studies | 22% ± 7% | |
myofibroblast cell | 4 studies | 23% ± 4% | |
conventional dendritic cell | 4 studies | 22% ± 3% | |
astrocyte | 3 studies | 17% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 11% |
Insufficient scRNA-seq data for expression of CDK2AP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4424.31 | 2641 / 2642 | 100% | 224.33 | 705 / 705 |
skin | 100% | 2905.40 | 1807 / 1809 | 100% | 128.90 | 472 / 472 |
lung | 100% | 2108.85 | 576 / 578 | 100% | 72.27 | 1154 / 1155 |
esophagus | 100% | 2571.58 | 1445 / 1445 | 99% | 74.89 | 182 / 183 |
ovary | 99% | 1430.39 | 179 / 180 | 100% | 113.95 | 430 / 430 |
uterus | 100% | 2870.62 | 170 / 170 | 99% | 85.88 | 456 / 459 |
breast | 100% | 2598.16 | 459 / 459 | 99% | 97.19 | 1110 / 1118 |
bladder | 100% | 2486.05 | 21 / 21 | 99% | 72.65 | 500 / 504 |
prostate | 100% | 2642.18 | 245 / 245 | 99% | 75.61 | 497 / 502 |
stomach | 100% | 1804.84 | 359 / 359 | 99% | 50.89 | 282 / 286 |
thymus | 100% | 1730.18 | 652 / 653 | 99% | 45.56 | 596 / 605 |
adrenal gland | 100% | 2095.12 | 258 / 258 | 98% | 75.84 | 226 / 230 |
intestine | 100% | 2245.56 | 963 / 966 | 98% | 48.12 | 517 / 527 |
kidney | 99% | 1571.88 | 88 / 89 | 97% | 44.77 | 873 / 901 |
pancreas | 87% | 748.64 | 285 / 328 | 98% | 62.98 | 175 / 178 |
liver | 70% | 575.96 | 158 / 226 | 55% | 18.78 | 225 / 406 |
adipose | 100% | 2502.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.76 | 1 / 1 |
blood vessel | 100% | 2675.47 | 1332 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 1131.59 | 236 / 241 | 0% | 0 | 0 / 0 |
muscle | 98% | 1420.91 | 786 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 52.90 | 78 / 80 |
heart | 95% | 1582.84 | 822 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 27.46 | 25 / 29 |
peripheral blood | 35% | 389.03 | 328 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0006261 | Biological process | DNA-templated DNA replication |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016581 | Cellular component | NuRD complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070182 | Molecular function | DNA polymerase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CDK2AP1 |
Protein name | Cyclin dependent kinase 2 associated protein 1 Cyclin-dependent kinase 2-associated protein 1 (CDK2-associated protein 1) (Deleted in oral cancer 1) (DOC-1) (Putative oral cancer suppressor) |
Synonyms | DOC1 CDKAP1 |
Description | FUNCTION: Inhibitor of cyclin-dependent kinase CDK2 (By similarity). Also acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin . . |
Accessions | ENST00000538446.5 [O14519-2] ENST00000535979.5 [O14519-2] ENST00000652466.1 [O14519-2] ENST00000535796.1 ENST00000544658.5 [O14519-2] ENST00000618072.4 [O14519-2] O14519 F5GZF0 ENST00000261692.7 [O14519-1] ENST00000542174.5 [O14519-2] |